Research

This week's research roundup features: Identification of caveolae-associated protein 4 autoantibodies as a biomarker of immune-mediated rippling muscle disease in adults.

By Samantha Rossi • August 16, 2022

This week's research roundup features: Type 1, type 2 myocardial infarction and non-ischemic myocardial injury-opinion from the front lines

By Samantha Rossi • August 9, 2022

This week's research roundup features: Gastrointestinal stromal tumors mimicking gynecologic disease: clinicopathological analysis of 20 cases.

By Samantha Rossi • August 2, 2022

This week's research roundup features: Motor-neuron-disease-like phenotype associated with IgLON5 disease.

By Samantha Rossi • July 26, 2022

This week's research roundup features: Structural Cardiac Abnormalities in Patients with Atrial Fibrillation-Flutter and Myocardial Injury.

By Chantell Canfield • July 19, 2022

This week's research roundup features: PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.

By Samantha Rossi • July 12, 2022

This week’s research roundup features: The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses. 

By Samantha Rossi • July 5, 2022

This week’s research roundup features: Understanding "Patient refuses" among 90+ year old patients with cancer or presumed cancer.

By Samantha Rossi • June 28, 2022

Featured Abstract: A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.

By Meghann Southwick • June 21, 2022

Featured Abstract: Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.

By Meghann Southwick • June 14, 2022

Featured abstract: Nuclear GSK-3β and oncogenic KRas lead to the retention of pancreatic ductal progenitor cells phenotypically similar to those seen in IPMN.

By Meghann Southwick • June 7, 2022

Featured abstract: Substance use screening in transplant populations.

By Meghann Southwick • May 31, 2022

Top highlights include: Monoclonal and oligoclonal anti-Platelet Factor 4 antibodies mediate VITT.

By Meghann Southwick • May 24, 2022